NNM Securities
ABOUT US
SERVICES
EQUITY
COMMODITY
CURRENCY
DERIVATIVES
MUTUAL FUND
ADVISORY
FINANCING
MARKET INFO
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
RESEARCH
CONTACT US
LOGIN
Gallery
Open Account Meon
Open Account
Partner Us
Downloads
COMPANY
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
more from company profile
General
Smart Quotes
Company Information
Comparison
Company News
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Cash Flow
Holdings
Share Holdings
MF Holdings
Digital Reports
Corp Actions
Board Meeting
Book Closure
Bonus Issues
Dividend Details
Price Info
Share Price
Historical Volume
Deliverable Volume
Bulk Deals
Block Deals
Price Charts
Home
Market Info
Company Profile
Financial Ratios
Financial Ratios
PFIZER LTD.
NSE :
PFIZER
BSE :
500680
ISIN CODE :
INE182A01018
Industry :
Pharmaceuticals & Drugs
House :
Pfizer - MNC
BSE
4119.75
12.4 (+0.3 %)
PREV CLOSE (
)
4107.35
OPEN PRICE (
)
4107.35
BID PRICE (QTY)
0.00 (0)
OFFER PRICE (QTY)
0.00 (0)
VOLUME
1064
TODAY'S LOW / HIGH (
)
4076.20
4155.00
52 WK LOW / HIGH (
)
3702.15
4940
NSE
4130.20
16.85 (+0.41 %)
PREV CLOSE(
)
4113.35
OPEN PRICE (
)
4113.35
BID PRICE (QTY)
4130.20 (1)
OFFER PRICE (QTY)
0.00 (0)
VOLUME
12557
TODAY'S LOW / HIGH(
)
4075.10
4149.00
52 WK LOW / HIGH (
)
3690
5000
Consolidated
Standalone
Select year
Nov2008
Nov2007
Nov2006
Nov2005
Nov2004
Particulars
Nov 2008
Nov 2007
Nov 2006
Nov 2005
Nov 2004
Operational & Financial Ratios
Earnings Per Share (Rs)
100.39
113.94
35.63
23.70
15.48
CEPS(Rs)
104.12
117.15
40.01
28.34
19.05
DPS(Rs)
12.50
27.50
12.50
10.00
10.00
Book NAV/Share(Rs)
301.96
216.74
142.90
113.68
96.68
Tax Rate(%)
28.52
24.67
34.62
36.77
40.16
Margin Ratios
Core EBITDA Margin(%)
19.12
19.60
20.80
15.91
13.04
EBIT Margin(%)
52.99
56.52
20.42
15.37
10.83
Pre Tax Margin(%)
52.99
56.52
20.41
15.34
10.71
PAT Margin (%)
37.88
42.58
13.35
9.70
6.41
Cash Profit Margin (%)
39.28
43.78
14.99
11.60
7.88
Performance Ratios
ROA(%)
18.37
26.37
10.07
9.39
9.35
ROE(%)
38.71
63.36
27.78
22.90
16.81
ROCE(%)
54.15
84.11
42.50
35.52
27.71
Asset Turnover(x)
0.48
0.62
0.75
0.97
1.46
Sales/Fixed Asset(x)
5.62
5.16
4.71
4.43
4.71
Working Capital/Sales(x)
1.00
1.42
2.34
2.89
3.32
Efficiency Ratios
Fixed Capital/Sales(x)
0.18
0.19
0.21
0.23
0.21
Receivable days
28.15
30.12
35.19
39.05
34.52
Inventory Days
50.96
44.60
43.53
41.49
43.07
Payable days
186.85
219.95
251.41
211.29
168.30
Valuation Parameters
PER(x)
4.66
5.68
21.73
37.96
37.58
PCE(x)
4.49
5.53
19.35
31.74
30.55
Price/Book(x)
1.55
2.99
5.42
7.91
6.02
Yield(%)
2.67
4.25
1.61
1.11
1.72
EV/Net Sales(x)
1.16
1.97
2.72
3.67
2.36
EV/Core EBITDA(x)
3.83
3.04
10.06
16.58
14.56
EV/EBIT(x)
2.03
3.22
12.31
22.09
20.27
EV/CE(x)
0.47
1.00
1.79
2.50
2.96
M Cap / Sales
1.89
2.62
3.14
3.98
2.59
Growth Ratio
Net Sales Growth(%)
0.03
0.03
9.11
4.32
14.45
Core EBITDA Growth(%)
-53.51
140.16
33.45
42.40
49.16
EBIT Growth(%)
-7.14
177.39
45.26
48.73
76.40
PAT Growth(%)
-11.89
219.75
50.33
58.64
88.22
EPS Growth(%)
-11.89
219.75
50.33
53.09
88.22
Financial Stability Ratios
Total Debt/Equity(x)
0.00
0.00
0.00
0.00
0.04
Current Ratio(x)
1.86
1.69
1.49
1.40
2.23
Quick Ratio(x)
1.72
1.57
1.35
1.26
1.79
Interest Cover(x)
NA
0.00
2275.76
712.58
92.80
Total Debt/Mcap(x)
0.00
0.00
0.00
0.00
0.01